Pregnancy: Clinical Trials

58 trials for Pregnancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 7 unknown, 4 recruiting, 3 withdrawn. 58 Phase 2, 16 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 258Completed 39, Unknown 7, Recruiting 4, Withdrawn 3, Not yet recruiting 2, Terminated 2, Active not recruiting 1
Phase 316Completed 9, Unknown 4, Recruiting 1, Terminated 1, Withdrawn 1
Phase 15Withdrawn 2, Active not recruiting 1, Completed 1, Unknown 1

Follow Pregnancy: new trials by email Literature Review of Pregnancy trials Research Report on Pregnancy

Trials (filtered) newest first · largest first

All 58 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
Contingency Management, Social Drivers of Health Screening - Pregnancy, Substance Use Disorder (SUD)
Phase 2Not yet recruitingWashington University School of Medicine2452027-01-012026-08-20
Impact of Standardization on Outcomes Following Cervical Ripening
Cervical Ripening with a double balloon catheter only, Cervical ripening with a double balloon catheter plus misoprostol, Usual-care control group - Pregnancy
Phase 2 / Phase 3RecruitingIndiana University11582026-07-292026-10-27
Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
DPP, 2PR, Free Choice - Pregnancy, HIV Infections
Phase 2Not yet recruitingHIV Prevention Trials Network3002026-05-152026-02-19
Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms
Cabergoline, Placebo - Pregnancy, Abortion
Phase 2RecruitingJefferson Drapkin3482026-03-162026-09-17
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
Lactiplantibacillus plantarum 299v, Placebo Capsule(s) - Iron Deficiency (ID), Pregnancy
Phase 2RecruitingUniversity of Illinois Chicago2502026-02-012026-11-02
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
CAB LA 600mg, RPV LA 900mg, CAB LA 400mg - HIV-1-infection, Pregnancy
Phase 1 / Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2025-05-012025-07-31
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1
FTC/TDF 200mg/300mg, FTC/TDF 300mg/450mg, FTC/TDF 400mg/600mg - HIV, Prevention
Phase 2CompletedUniversity of North Carolina, Chapel Hill542024-06-182026-02-17
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
Rifapentine, Isoniazid - HIV Seropositivity, Pregnancy
Phase 1 / Phase 2Active not recruitingThe Aurum Institute NPC2522024-01-172025-12-12
Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)
Mirtazapine - Pregnancy, Severe Nausea and Vomiting
Phase 1 / Phase 2WithdrawnNorthwestern University2022-06-132024-12-11
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation
30 mg letrozole followed by 800 mcg misoprostol - Pregnancy
Phase 2CompletedGynuity Health Projects402021-12-092022-06-15
Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.
Tenofovir Disoproxil Fumarate - Hepatitis B, Tenofovir
Phase 2CompletedUniversity of Oxford272021-01-082024-03-27
Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy
Magnitude Group, Frequency Group - Opiate Addiction, Pregnancy
Phase 2TerminatedSteve N. Caritis, MD132019-04-132024-08-29
The Effect of Probiotics on Maintenance of Health in Pregnancy and Infants
Probiotic, Placebo - Pregnancy
Phase 2CompletedLallemand Health Solutions1802017-10-232023-02-02
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
17 OHPC - Pregnancy, Preeclampsia (PE)
Phase 2RecruitingUniversity of Mississippi Medical Center602017-05-222026-05-01
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
Dolutegravir 50mg od, Standard of Care - HIV, Pregnancy
Phase 2 / Phase 3CompletedUniversity of Liverpool602017-03-142025-09-04
Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)
Citrulline, Placebo - Pre-eclampsia, Pregnancy
Phase 2 / Phase 3CompletedNantes University Hospital1162017-02-202026-09-14
Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?
Ibuprofen - Ovulation, Ovulation Inhibition
Phase 2CompletedInsel Gruppe AG, University Hospital Bern512016-01-012024-11-19
Thrombocytopenia in Gestational Period
Dexamethasone - Immune Thrombocytopenia, Pregnancy
Phase 2 / Phase 3UnknownPeking University People's Hospital702016-01-012016-04-26
Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Raltegravir, Lopinavir/Ritonavir - HIV, Pregnancy
Phase 2 / Phase 3TerminatedFundação Bahiana de Infectologia332015-06-012024-10-15
Biomarker Feedback to Motivate Cessation in Pregnancy
Biomarker feedback (phone based smoking cessation counseling), Control condition (phone based smoking cessation counseling) - Nicotine Dependence, Pregnancy
Phase 2CompletedMayo Clinic602015-03-012017-12-19

Showing 20 of 58. Sign in to see all of them.

Narrower conditions

Pre-Eclampsia (4)  ·  Behavior (3)  ·  HIV Infections (3)  ·  Breast Feeding (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Hypotension (2)  ·  Obesity (2)  ·  Smoking Cessation (2)  ·  Substance-Related Disorders (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Agnosia (1)  ·  Depression (1)  ·  Diabetes, Gestational (1)  ·  Disease Progression (1)  ·  Fetal Membranes, Premature Rupture (1)

Broader conditions

Urogenital Diseases (14)  ·  Infections (10)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Communicable Diseases (7)  ·  Genital Diseases (7)  ·  Pregnancy Complications (7)  ·  Virus Diseases (7)  ·  Behavior (6)  ·  Blood-Borne Infections (6)  ·  Immune System Diseases (6)  ·  RNA Virus Infections (6)  ·  Immunologic Deficiency Syndromes (5)  ·  Lentivirus Infections (5)  ·  Nutritional and Metabolic Diseases (5)

Interventions

Misoprostol (4)  ·  Tenofovir (3)  ·  Insulin (2)  ·  Lopinavir (2)  ·  Metformin (2)  ·  Raltegravir Potassium (2)  ·  17-alpha-Hydroxyprogesterone (1)  ·  Activities of Daily Living (1)  ·  Acupuncture Therapy (1)  ·  Biological Products (1)  ·  Blood Specimen Collection (1)  ·  BufferGel (1)  ·  Bupivacaine (1)  ·  Bupropion (1)  ·  Cabergoline (1)

Sponsors

University of North Carolina, Chapel Hill (4)  ·  Gynuity Health Projects (2)  ·  Mansoura University (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Auerbach Hematology Oncology Associates P C (1)  ·  Centers for Disease Control and Prevention (1)  ·  Dilafor AB (1)  ·  Dow University of Health Sciences (1)  ·  Edgard Costa de Vilhena (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Fundação Bahiana de Infectologia (1)  ·  Gonabad University of Medical Sciences (1)  ·  HIV Prevention Trials Network (1)

Countries

United States (24)  ·  South Africa (4)  ·  Brazil (2)  ·  Canada (2)  ·  Egypt (2)  ·  France (2)  ·  Mexico (2)  ·  Uganda (2)  ·  Zambia (2)  ·  Zimbabwe (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Bolivia (1)  ·  Cambodia (1)  ·  China (1)

Top investigators

Abdullah Baqui, MBBS (1)  ·  Adalberto Sanchez, PhD (1)  ·  Albert Moore, MD (1)  ·  Allan M Cyna, FRCA (1)  ·  Ana A Baumann, PhD (1)  ·  Ana C Plata, MSc (1)  ·  Ashley Hickman, MD (1)  ·  Asnat Walfisch, MD (1)  ·  Babbette LaMarca, PhD (1)  ·  Benjamin Chi, MD, MSc (1)  ·  Benjamin H Chi, MD (1)  ·  Beverly Winikoff, MD, MPH (1)  ·  Carlo Contini, Professor (1)  ·  Carlos Brites, MD, PhD (1)  ·  Christi A Patten, PhD (1)

Results publications

PMID 16966110, PMID 17766603, PMID 17997151, PMID 18520682, PMID 18987623, PMID 19104016, PMID 19307941, PMID 19886836, PMID 19919718, PMID 20842042, PMID 21091415, PMID 21199294, PMID 21861025, PMID 21928117, PMID 22761006, PMID 23096052, PMID 23587190, PMID 23864647, PMID 23867137, PMID 23998516, PMID 24652353, PMID 24704179, PMID 24937546, PMID 25225008, PMID 25874236, PMID 26066384, PMID 26592857, PMID 27004997, PMID 27079291, PMID 27506771, PMID 27872513, PMID 28660118, PMID 28739199, PMID 28741272, PMID 28752805, PMID 30831103, PMID 31539371, PMID 32120420, PMID 32661003, PMID 33015104, PMID 33346335, PMID 36996264, PMID 37230961, PMID 38462256, PMID 39077939, PMID 39638148

NIH funding

K23HL106231 (1), R01AI157859 (1), R01DA019180 (1), R01HD096796 (1), R21HD105101 (1), U10HD047905 (1), UM1AI068619 (1)